Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

KETOTIFEN: 5,209 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
5,209
Total FAERS Reports
9 (0.2%)
Deaths Reported
99
Hospitalizations
5,209
As Primary/Secondary Suspect
33
Life-Threatening
10
Disabilities
Dec 1, 2006
FDA Approved
CVS Pharmacy
Manufacturer
Discontinued
Status
Yes
Generic Available

Active Ingredient: KETOTIFEN FUMARATE · Drug Class: Histamine H1 Receptor Antagonists [MoA] · Route: OPHTHALMIC · Manufacturer: CVS Pharmacy · FDA Application: 021066 · HUMAN OTC DRUG · FDA Label: Available

Patent Expires: Mar 27, 2028 · First Report: 20011223 · Latest Report: 20250910

What Are the Most Common KETOTIFEN Side Effects?

#1 Most Reported
Treatment failure
3,038 reports (58.3%)
#2 Most Reported
Drug ineffective
798 reports (15.3%)
#3 Most Reported
Eye irritation
455 reports (8.7%)

All KETOTIFEN Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Treatment failure 3,038 58.3% 0 1
Drug ineffective 798 15.3% 1 9
Eye irritation 455 8.7% 0 0
Eye pain 208 4.0% 0 0
Ocular hyperaemia 166 3.2% 0 0
Eye pruritus 164 3.2% 1 0
Hypersensitivity 102 2.0% 0 3
Vision blurred 87 1.7% 0 0
Condition aggravated 83 1.6% 1 10
Eye swelling 72 1.4% 0 0
Product quality issue 55 1.1% 0 0
Dizziness 52 1.0% 0 2
Dry eye 51 1.0% 0 2
Pruritus 47 0.9% 0 2
Lacrimation increased 43 0.8% 0 0
Off label use 43 0.8% 0 7
Expired product administered 39 0.8% 0 0
Product use in unapproved indication 38 0.7% 0 8
Instillation site pain 36 0.7% 0 0
Burning sensation 35 0.7% 0 2

Who Reports KETOTIFEN Side Effects? Age & Gender Data

Gender: 73.1% female, 26.9% male. Average age: 57.8 years. Most reports from: US. View detailed demographics →

Is KETOTIFEN Getting Safer? Reports by Year

YearReportsDeathsHosp.
2001 4 0 4
2002 3 0 2
2006 1 0 0
2007 1 0 0
2009 1 0 0
2010 1 0 0
2013 4 0 0
2014 46 1 3
2015 116 0 1
2016 132 0 4
2017 126 0 16
2018 72 0 1
2019 89 0 8
2020 81 0 7
2021 62 0 11
2022 44 0 0
2023 55 1 4
2024 38 0 0
2025 17 0 1

View full timeline →

What Is KETOTIFEN Used For?

IndicationReports
Product used for unknown indication 4,052
Eye pruritus 291
Eye allergy 210
Hypersensitivity 179
Dry eye 80
Mast cell activation syndrome 47
Eye irritation 44
Ocular hyperaemia 39
Seasonal allergy 32
Lacrimation increased 30

KETOTIFEN vs Alternatives: Which Is Safer?

KETOTIFEN vs KLONOPIN KETOTIFEN vs L-ASPARAGINASE KETOTIFEN vs LABETALOL KETOTIFEN vs LABETALOL\LABETALOL KETOTIFEN vs LACIDIPINE KETOTIFEN vs LACOSAMIDE KETOTIFEN vs LACTOBACILLUS ACIDOPHILUS KETOTIFEN vs LACTOBACILLUS RHAMNOSUS KETOTIFEN vs LACTOSE KETOTIFEN vs LACTULOSE

Other Drugs in Same Class: Histamine H1 Receptor Antagonists [MoA]

Official FDA Label for KETOTIFEN

Official prescribing information from the FDA-approved drug label.

FDA Approved Uses (Indications)

Uses For the temporary relief of itchy eyes due to ragweed, pollen, grass, animal hair and dander.

Dosage & Administration

Directions

  • adults and children 3 years and older:
  • put 1 drop in the affected eye(s) twice daily, every 8-12 hours, no more than twice per day
  • if using other ophthalmic products while using this product, wait at least 5 minutes between each product
  • children under 3 years of age: consult a doctor Other information store at 4-25 °C (39-77 °F)

Warnings

Warnings For external use only Do not use

  • if you are sensitive to any ingredient in this product
  • if solution changes color or becomes cloudy
  • to treat contact lens related irritation When using this product
  • remove contact lenses before use
  • wait at least 10 minutes before re-inserting contact lenses after use
  • do not touch tip of container to any surface to avoid contamination
  • replace cap after each use Stop use and ask doctor if you experience any of the following:
  • eye pain
  • changes in vision
  • redness of the eyes
  • itching that worsens or lasts more than 72 hours Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Active Ingredient

Active ingredient Purpose Ketotifen (0.025%) (equivalent to ketotifen fumarate 0.035%) Antihistamine

Inactive Ingredients

Inactive ingredients benzalkonium chloride 0.01%, glycerin, hydrochloric acid and/or sodium hydroxide, water for injection Questions or comments? [phone icon]Call: 1-800-632-6900 DISTRIBUTED BY: THE KROGER CO., CINCINNATI, OHIO 45202 PRODUCT OF ITALY *Systane® and Zaditor® are registered trademarks of Alcon, Inc., Fribourg, Switzerland CH-1701. Alcon, Inc. is not affiliated with The Kroger Co. or this product. QUALITY GUARANTEE 1-800-632-6900 www.kroger.com 9767401 MK60107